These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 24119210)
1. Nutrition and nutraceutical supplements for the treatment of hypertension: part III. Houston M J Clin Hypertens (Greenwich); 2013 Dec; 15(12):931-7. PubMed ID: 24119210 [TBL] [Abstract][Full Text] [Related]
2. Nutrition and nutraceutical supplements for the treatment of hypertension: part II. Houston M J Clin Hypertens (Greenwich); 2013 Nov; 15(11):845-51. PubMed ID: 24119236 [TBL] [Abstract][Full Text] [Related]
3. Nutrition and nutraceutical supplements for the treatment of hypertension: part I. Houston M J Clin Hypertens (Greenwich); 2013 Oct; 15(10):752-7. PubMed ID: 24088285 [TBL] [Abstract][Full Text] [Related]
4. The role of nutrition and nutraceutical supplements in the treatment of hypertension. Houston M World J Cardiol; 2014 Feb; 6(2):38-66. PubMed ID: 24575172 [TBL] [Abstract][Full Text] [Related]
5. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Houston MC Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494 [TBL] [Abstract][Full Text] [Related]
6. Nutrition and nutraceutical supplements in the treatment of hypertension. Houston MC Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):821-33. PubMed ID: 20528640 [TBL] [Abstract][Full Text] [Related]
7. The role of nutrition, nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Houston MC Altern Ther Health Med; 2013; 19 Suppl 1():32-49. PubMed ID: 23981465 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Houston MC Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):681-91. PubMed ID: 17605647 [TBL] [Abstract][Full Text] [Related]
9. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Houston MC Prog Cardiovasc Dis; 2005; 47(6):396-449. PubMed ID: 16115519 [TBL] [Abstract][Full Text] [Related]
10. Impact of Micronutrients on Hypertension: Evidence from Clinical Trials with a Special Focus on Meta-Analysis. Chiu HF; Venkatakrishnan K; Golovinskaia O; Wang CK Nutrients; 2021 Feb; 13(2):. PubMed ID: 33578935 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Montezano AC; Dulak-Lis M; Tsiropoulou S; Harvey A; Briones AM; Touyz RM Can J Cardiol; 2015 May; 31(5):631-41. PubMed ID: 25936489 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician. Montezano AC; Touyz RM Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098 [TBL] [Abstract][Full Text] [Related]
14. Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial. Cicero AFG; Colletti A; Fogacci F; Bove M; Giovannini M; Borghi C High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):401-405. PubMed ID: 30471072 [TBL] [Abstract][Full Text] [Related]
15. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Khan NA; Hemmelgarn B; Herman RJ; Bell CM; Mahon JL; Leiter LA; Rabkin SW; Hill MD; Padwal R; Touyz RM; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Moe G; Prasad R; Arnold MO; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; DeChamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Bacon SL; Lindsay P; Gilbert RE; Lewanczuk RZ; Tobe S; Can J Cardiol; 2009 May; 25(5):287-98. PubMed ID: 19417859 [TBL] [Abstract][Full Text] [Related]
16. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW; Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage. Coats A; Jain S J Hum Hypertens; 2017 Jun; 31(6):376-381. PubMed ID: 28252041 [TBL] [Abstract][Full Text] [Related]
18. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Siti HN; Kamisah Y; Kamsiah J Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516 [TBL] [Abstract][Full Text] [Related]